Pelthos Therapeutics Inc. <PTHS.A>: Oppenheimer cuts target price to $64 from $66
PTHS•Related News
Estée Lauder partners with University of Leeds to advance complexion shade-matching research
EL•
Nasdaq Trade Halt <STRRP.O> News and Resumption Times at 09:00 AM
STRRP•
Boost Run gains after Q2 revenue jump
BRUN•
BHAV Acquisition Q2 FY26 net income rises to $701,173; six-month net income increases to $713,174
BHAV•
Lantern Pharma Reports Second Quarter 2026 Financial Results And Provides Business Update
LTRN•